Abstract
Alopecia can be a psychologically daunting prospect for people requiring cancer chemotherapy. Fortunately, most patients experience only temporary hair loss. We report the case of a 23-year-old woman with chronic myeloid leukaemia who developed permanent, near-total alopecia of her scalp, eyebrows, eyelashes, axillary and public hair following busulphan and cyclophosphamide chemotherapy which was used as conditioning prior to allogeneic bone marrow transplantation. The histology from a scalp biopsy revealed hair follicle destruction. Topical minoxidil failed to induce significant re-growth.
MeSH terms
-
Adult
-
Alopecia / chemically induced*
-
Alopecia / drug therapy
-
Antineoplastic Agents, Alkylating / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Bone Marrow Purging / adverse effects
-
Bone Marrow Transplantation / adverse effects*
-
Busulfan / adverse effects
-
Cyclophosphamide / adverse effects
-
Female
-
Hair Follicle / drug effects
-
Humans
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
-
Minoxidil / therapeutic use
Substances
-
Antineoplastic Agents, Alkylating
-
Minoxidil
-
Cyclophosphamide
-
Busulfan